To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open120.9
High129
Low118.95
Prev. Close118.15
Avg. Traded Price124.66
Volume25,750

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
000
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

118.957 hours ago
129.003 hours ago
arrow

LOWER/UPPER CIRCUITS

106.35
129.95
arrow
Parnax Lab Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Net Profit,rose 19.87% in the last year to ₹11.52 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
notePrice to Earning Ratio,is 11.78, lower than its sector PE ratio of 43.54.
noteQuarterly Revenue,rose 5.76% YoY to ₹49.46 Cr. Its sector's average revenue growth YoY for the quarter was 11.41%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 30.9%
Net profit growth 5Y CAGR : 23.84%
Parnax Lab Limited (formerly Krishna Deep Trade & Investment Limited) is principally engaged in the business activities of manufacturing and export of Pharmaceutical Formulations. The company’s manufacturing facilities extend to a number of sectors, namely Pharmaceuticals, Cosmetic, Herbal (Ayurvedic Medicine) and Nutraceutical (FSSAI). In addition to its facility in Silvassa, Naxpar recently commenced operations at its state of the art manufacturing unit in Baddi, Himachal Pradesh.
personal

Grow your wealth with more research recommendations

+91